Valsartan
Back to searchMolecule Structure
Scientific Name
Valsartan
Description of the Drug
Valsartan is an angiotensin-receptor blocker used to manage hypertension alone or in combination with other antihypertensive agents and to manage heart failure in patients who are intolerant to ACE inhibitors.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00177
http://www.drugbank.ca/drugs/DB00177
Brand Name(s)
Diovan, Exforge, Prexxartan, Valsartan
Company Owner(s)
Alkem Laboratories Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Watson Laboratories Inc, Mylan Pharmaceuticals Inc, Amneal Pharmaceuticals Of New York Llc, Novartis Pharmaceuticals Corp, Allergan Sales Llc, Novitium Pharma Llc, Prinston Pharmaceutical Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Type-1 angiotensin II receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL227 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL2542 | |||||
| PharmGKB | PA451848 | |||||
| Human Metabolome Database | HMDB0014323 | |||||
| DrugBank | DB00177 | |||||
| PubChem: Thomson Pharma | 14856825 | 99228303 | 14881173 | |||
| PubChem | 60846 | |||||
| Mcule | MCULE-6728882368 | MCULE-8348485974 | ||||
| LINCS | LSM-2993 | |||||
| Nikkaji | J550.722G | |||||
| PDBe | U35 | |||||
| BindingDB | 50049186 | |||||
| DrugCentral | 2806 | |||||
| ChemicalBook | CB23133442 | CB3952405 | CB6182539 | CB53133443 | CB34813436 | CB14657818 |
| Guide to Pharmacology | 3937 | 593 | ||||
| rxnorm | EXFORGE | VALSARTAN | DIOVAN | |||
| PubChem: Drugs of the Future | 123055291 | |||||
| ChEBI | 9927 | |||||
| ZINC | ZINC000003875259 |
